Turning Point Benefit Group’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
45,583
+15,285
+50% +$368K 0.69% 36
2025
Q4
$733K Sell
30,298
-8,514
-22% -$206K 0.38% 46
2025
Q3
$938K Sell
38,812
-3,586
-8% -$86.3K 0.57% 37
2025
Q2
$1.02M Buy
+42,398
New +$1.01M 0.77% 26
2025
Q1
Sell
-44,973
Closed -$1.05M 69
2024
Q4
$1.05M Buy
+44,973
New +$1.07M 1% 14

Other funds holding IBD

Turning Point Benefit Group's IBD Position: Q1 2026 in Review

Turning Point Benefit Group increased its Inspire Corporate Bond ETF (IBD) stake by 50% in Q1 2026, buying an estimated $368K and bringing the position to 45,583 shares worth $1.09M. The position accounts for 0.69% of the portfolio, ranked #36.

Turning Point Benefit Group first reported a position in IBD in Q4 2024 and has held it in 5 quarters since. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • Turning Point Benefit Group held 45,583 shares of Inspire Corporate Bond ETF worth $1.09M as of Q1 2026.
  • Turning Point Benefit Group bought 15,285 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $368K.
  • Inspire Corporate Bond ETF made up 0.69% of Turning Point Benefit Group's portfolio in Q1 2026, its #36 holding.
  • Turning Point Benefit Group first reported a position in Inspire Corporate Bond ETF in Q4 2024 and has held it in 5 quarters since.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.